(Stearyl, Norleucine17) VIP hybrid antagonizes VIP receptors on non-small cell lung cancer cells

Terry W. Moody, J. Leyton, T. Coelho, S. Jakowlew, K. Takahashi, F. Jameison, M. Koh, M. Fridkin, I. Gozes, M. Knight

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of '(Stearyl, Norleucine17) VIP hybrid antagonizes VIP receptors on non-small cell lung cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry